Literature DB >> 3402523

Plasma and skin blister fluid concentrations of trimethoprim following its oral administration.

A Klimowicz1, A Nowak, M Kadyków.   

Abstract

Plasma and skin blister fluid concentration-time curves following a single oral dose of trimethoprim have been evaluated. Skin blisters were produced by the cantharides technique, using patches with cantharidin ointment. Trimethoprim concentrations in plasma following multiple doses of 200 mg were also determined. The maximal concentration in plasma after a single oral dose of 400 mg trimethoprim was 3.95 +/- 1.08 mg/l, and it was observed after 2 h, whereas in skin blister fluid the level was 2.21 +/- 0.62 mg/l, and it was delayed for up to 6 h. This means that a certain time is required for drug transfer from the capillaries via the basal membrane into blister fluid. Penetration of the drug into blister fluid, defined as the ratio of the areas under the trimethoprim level time curve in skin blister fluid to that of plasma, was 0.826 +/- 0.096. The steady-state concentration of trimethoprim in plasma during routine treatment with 200-mg doses ranged between 2 and 3.5 mg/l.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3402523     DOI: 10.1007/bf00542439

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

Review 1.  Mechanism of action of trimethoprim-sulfamethoxazole. II.

Authors:  J J Burchall
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

Review 2.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

Authors:  S R Bushby
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

3.  Suction blister device for separation of viable epidermis from dermis.

Authors:  U Kiistala
Journal:  J Invest Dermatol       Date:  1968-02       Impact factor: 8.551

4.  Assay and pharmacokinetics of trimethoprim in man and animals.

Authors:  D E Schwartz; W H Ziegler
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

5.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

6.  [Role of the skin in the distribution of trimethoprim].

Authors:  A Nowak; M Kadyków; A Klimowicz
Journal:  Pol Tyg Lek       Date:  1983-08-29

7.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

8.  Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid.

Authors:  J N Bruun; N Ostby; J E Bredesen; P Kierulf; P K Lunde
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

9.  Pharmacokinetics of two dosage levels of trimethoprim to 'steady-state' in normal volunteers.

Authors:  I D Watson; M J Stewart; A Wiles; S J McIntosh
Journal:  J Int Med Res       Date:  1983       Impact factor: 1.671

10.  Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.

Authors:  R Wise; I A Donovan; C A McNulty; R Waldron; J M Andrews
Journal:  J Hosp Infect       Date:  1986-03       Impact factor: 3.926

View more
  4 in total

1.  Penetration of tinidazole into skin blister fluid following its oral administration.

Authors:  A Klimowicz; A Nowak; S Bielecka-Grzela
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Two-stage penetration of a single oral dose of sulphadimethoxine into skin blister fluid.

Authors:  A Nowak; A Klimowicz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.

Authors:  Karen Rowland Yeo; Jane R Kenny; Amin Rostami-Hodjegan
Journal:  Eur J Clin Pharmacol       Date:  2013-01-11       Impact factor: 2.953

4.  A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions.

Authors:  Denise Türk; Nina Hanke; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2020-11-10       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.